238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.72%
Revenue growth under 50% of BIDU's 30.26%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.22%
Gross profit growth under 50% of BIDU's 36.14%. Michael Burry would be concerned about a severe competitive disadvantage.
8.50%
EBIT growth below 50% of BIDU's 60.98%. Michael Burry would suspect deeper competitive or cost structure issues.
8.50%
Operating income growth under 50% of BIDU's 60.98%. Michael Burry would be concerned about deeper cost or sales issues.
11.83%
Net income growth under 50% of BIDU's 49.51%. Michael Burry would suspect the firm is falling well behind a key competitor.
-3.85%
Negative EPS growth while BIDU is at 50.59%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.85%
Negative diluted EPS growth while BIDU is at 51.19%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.33%
Share count expansion well above BIDU's 0.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.29%
Diluted share count expanding well above BIDU's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
5.56%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
21.14%
Positive FCF growth while BIDU is negative. John Neff would see a strong competitive edge in net cash generation.
914.80%
10Y revenue/share CAGR under 50% of BIDU's 19392.52%. Michael Burry would suspect a lasting competitive disadvantage.
142.25%
5Y revenue/share CAGR under 50% of BIDU's 757.27%. Michael Burry would suspect a significant competitive gap or product weakness.
38.63%
3Y revenue/share CAGR under 50% of BIDU's 201.97%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
786.32%
OCF/share CAGR of 786.32% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
212.23%
OCF/share CAGR of 212.23% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
56.91%
3Y OCF/share CAGR of 56.91% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
808.83%
Below 50% of BIDU's 24804.55%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
99.11%
Below 50% of BIDU's 333.01%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
34.82%
3Y net income/share CAGR 1.25-1.5x BIDU's 31.42%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
2140.75%
Below 50% of BIDU's 178423.50%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
156.52%
Below 50% of BIDU's 873.05%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
64.97%
Below 50% of BIDU's 198.77%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.82%
Firm’s AR is declining while BIDU shows 7.63%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
55.37%
Inventory growth well above BIDU's 20.19%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.05%
Asset growth well under 50% of BIDU's 19.44%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.74%
Under 50% of BIDU's 11.38%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.04%
We’re deleveraging while BIDU stands at 39.07%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.31%
R&D dropping or stable vs. BIDU's 18.65%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-4.65%
We cut SG&A while BIDU invests at 31.55%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.